Back to search

Article

BET inhibitor blocks the oncogenic function of nucleophosmin 1 in castration-resistant prostate cancer by interfering with the c-Myc signaling pathway

2022-05-31

Abstract excerpt

<h4>Background: </h4> Nucleophosmin 1 (NPM1) is a multifunctional protein that promotes tumor progression in some solid tumors and has also been reported to be capable of predicting poor prognosis of prostate cancer (PCa). However, whether and how NPM1 exerts such malignant potentials in castration-resistant prostate cancer (CRPC) remain elusive. <h4>Methods: </h4>: The effects of NPM1 on PCa and CRPC and the inte...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2d5a109b-6618-5685-aabb-5cd0699cd863
DOI
10.21203/rs.3.rs-1659620/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
BET inhibitor blocks the oncogenic function of nucleophosmin 1 in castration-resistant prostate cancer by interfering with the c-Myc signaling pathwayDOI 10.21203/rs.3.rs-1659620/v1
Select a neighboring publication to make it the new centre.